Abiopharma

Clinical trial NCT07279935 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-31 → 2026-05-26

Clinical trial NCT03670368 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-05-31 → 2025-08-21 3. primary completion date: 2026-05-31 → 2025-08-21 4. enrollment: 500 → 416 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07394140 updates: 1. start date: 2026-02-01 → 2026-06-15 2. primary completion date: 2026-05-31 → 2026-10-31

Clinical trial NCT06360354 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2029-02-25 → 2026-11-30 3. primary completion date: 2027-02-26 → 2026-10-31 4. enrollment: 350 → 120 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05951959 updates: 1. completion date: 2028-07-07 → 2028-10-31 2. primary completion date: 2028-07-07 → 2028-10-31

Clinical trial NCT07286188: primary completion date: 2026-07-01 → 2026-12-01.

ResMed Inc. Daily Stock Update

Robbins LLP is Investigating Allegations that the Officers and Directors of Beta Bionics, Inc. (BBNX) Violated Securities Laws and Breached Fiduciary Duties to Shareholders

NYT Investors Have the Opportunity to Join Investigation of The New York Times Company with the Schall Law Firm

PIMCO Closed-End Funds Declare Monthly Common Share Distributions